Inspire Veterinary Partners Faces Nasdaq Delisting Over Bid Price Noncompliance
Inspire Veterinary Partners Inc. has received a notice from the Nasdaq Stock Market stating that the company is not in compliance with the minimum bid price requirement for continued listing. The notice cites that Inspire's common stock failed to meet the minimum bid price for 30 consecutive business days and is not eligible for a compliance period due to recent reverse stock splits. Nasdaq has indicated that trading of the company's securities will be suspended on November 24, 2025, unless Inspire requests a hearing by November 20, 2025. The company plans to request a hearing, which will temporarily halt any suspension or delisting actions pending the outcome. There is no assurance that Inspire will be able to regain compliance or maintain its Nasdaq listing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Veterinary Partners Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-111267), on November 17, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。